Propecia vs Avodart: Which DHT Blocker Is Best for Hair Loss in 2025?

Finasteride tablets bottles against the orange background.

Both Propecia (finasteride) and Avodart (dutasteride) lower DHT, a hormone that shrinks hair follicles over time. Finasteride is FDA-approved for hair loss and blocks about 70% of scalp DHT. Dutasteride blocks closer to 90% and may regrow more hair, but it is off-label in the U.S.

DrugScalp DHT DropFDA Approved?Daily DoseCostBest For
Finasteride~70%Yes1 mg$10–20/monthEarly or mild loss, first-line treatment
Dutasteride~90%No0.5 mg$20–40/monthMore aggressive loss or poor response to finasteride

Propecia vs Avodart: Key Takeaways

  • Finasteride (Propecia) and dutasteride (Avodart) both block DHT, the hormone responsible for miniaturizing hair follicles.
  • Finasteride reduces scalp DHT by ~70% and is FDA-approved for hair loss; dutasteride reduces it by ~90% and is more potent but off-label in the U.S.
  • Both medications are generally well-tolerated, but some users experience sexual or mood side effects.
  • Treatment choice depends on age, family history, response to other therapies, and tolerance of risk.

If you’re comparing options after hearing about DHT blockers online, or you’ve already tried minoxidil, this article breaks down the real differences between Propecia and Avodart based on the latest research and expert consensus.

How These Drugs Work in Hair Follicles

Androgenetic alopecia is driven by DHT (dihydrotestosterone), a hormone made when testosterone is converted by an enzyme called 5-alpha reductase. DHT miniaturizes hair follicles, causing them to shrink and produce thinner, shorter hairs until they eventually stop growing.

Finasteride and dutasteride are 5-alpha reductase inhibitors that reduce this DHT-driven miniaturization.

But which drug is more effective?

A man with a case of male alopecia.

Finasteride ≈ 70% scalp DHT drop

Finasteride blocks type II 5-alpha reductase, the version mainly found in hair follicles. Taking 1 mg daily reduces scalp DHT by about 60–70%. That’s enough to slow or halt loss in most men with early to moderate thinning.

Dutasteride ≈ 90% scalp DHT drop

Dutasteride blocks both type I and type II enzymes. Type I is found in the skin and sebaceous glands, while type II targets the follicle. That dual action drops DHT levels by 90% or more.

Efficacy for Hair Regrowth

Recent clinical data suggest that while both finasteride and dutasteride promote hair regrowth, dutasteride may offer superior results.

  • In a 2014 randomized trial involving 917 men, dutasteride 0.5 mg led to a greater increase in hair count and shaft thickness within a 2.54 cm target area compared to both finasteride and placebo. Frontal scalp photographs taken over a 24-week period also showed more noticeable improvement with dutasteride. These effects were dose-dependent, reinforcing the drug’s potency as a dual 5-alpha reductase inhibitor.
  • More recently, a 2025 network meta-analysis (Gupta et al., JAMA Dermatol) comparing various hair loss treatments ranked oral dutasteride 0.5 mg as the most effective medical therapy for male pattern hair loss (dutasteride 0.5 mg/day, taken orally, was more effective than either oral finasteride 1 mg/day or oral minoxidil 5 mg/day). Dutasteride outperformed finasteride and all minoxidil formulations in terms of increasing total and terminal hair density at 24 and 48 weeks.

On average, men taking dutasteride saw better density gains in less time, especially in the crown area. That said, finasteride still works well for most men, particularly if you start early.

Side-Effect Snapshot

Erectile dysfunction is the most frequently reported issue, followed by decreased ejaculatory volume and reduced libido. These effects appear in a small percentage of users and are typically dose-dependent and reversible upon discontinuation.

Sexual Dysfunction

Sexual adverse effects are the most frequently reported complications associated with finasteride use. Erectile dysfunction is the most common, followed by ejaculatory dysfunction and loss of libido.

Male reproductive anatomy model and a doctor explaining the sexual dysfunction side effects of DHT blockers.

In studies where patients were prescribed finasteride at 5 mg per day, findings indicate:

  • Erectile dysfunction was reported in 3.4% to 15.8% of patients, compared to 1.7% to 6.3% in those on placebo.
  • Decreased libido affected 2.36% to 10.0% of patients, versus 1.2% to 6.3% in the placebo group.
  • Ejaculatory dysfunction occurred in 0.9% to 5.7% of patients, while 0.5% to 1.7% of placebo patients experienced it.

These side effects are usually mild and reversible when the medication is stopped.

Like finasteride users, some men taking dutasteride have reported sexual dysfunction. One study of dutasteride use in men with BPH found that:

  • Erectile dysfunction occurred in 7.3%,
  • Decreased libido in 4.2%,
  • And ejaculation disturbances in 2.2% of patients.

Crucially, head-to-head trials for hair loss have found no statistically significant difference in sexual side effect rates between finasteride and dutasteride.8

Mood and Depression

There have been reports (mostly post-marketing) of mood changes, depression, and anxiety in some men taking 5-AR inhibitors. A 2020 pharmacovigilance analysis and a 2025 review highlighted a signal for increased reports of depression and suicidal ideation in finasteride users, particularly younger men.

While causation isn’t proven, the FDA added warnings about potential mood side effects. Dutasteride, by analogy, could have similar effects, though data are more limited. Overall, the risk appears low, but patients and doctors are advised to monitor for mood symptoms.

Pregnancy & Fetal Development

Women must not use or come into contact with these drugs if pregnant. Finasteride and dutasteride can cause birth defects in a male fetus by disrupting DHT (which is crucial for male genital development).

A pregnant woman’s belly.

Dutasteride carries a greater risk because its half-life is 5-6 weeks, significantly longer than finasteride’s 4-6 hours.

Strategies to Mitigate Risk

  • Quarter-dosing: Some men cut pills into quarters to find the lowest effective dose.
  • Alternate-day use: Especially with dutasteride, which stays in your system longer.
  • Cycle on/off: The concept of periodic breaks (e.g., 1–2 weeks off every few months) is discussed anecdotally to possibly reset any side effects.
  • Topical versions: Especially finasteride. Lower systemic absorption, similar local DHT reduction.

FDA vs Off-Label Status

Finasteride (Propecia) is FDA-approved for male pattern hair loss at 1 mg/day. It’s the gold standard first-line prescription for AGA.

Dutasteride (Avodart) is not FDA-approved for hair loss. The medication is FDA-approved for the treatment of BPH, but its use for hair loss is considered off-label.

What that means in practice: Physicians can legally prescribe dutasteride for androgenetic alopecia if they determine it’s medically appropriate. However, insurance may not cover the cost, and you’ll need to provide informed consent acknowledging the off-label use.

International note: Dutasteride is officially approved for hair loss in Japan, South Korea, and Taiwan. In Asia, it’s often the first-line choice.

A doctor explaining dosing and side effects of DHT blocker medication.

Choosing the Right Option

Age and Family History

If you’re in your 20s or early 30s with gradual thinning, finasteride is usually enough. Especially if you have a moderate family history or your hairline is just starting to recede.

If you’re noticing fast progression or have a family history of early baldness, dutasteride might be the stronger preventive play.

Combo Therapy with Minoxidil / LLLT / PRP

Stacking treatments improves your odds. Here are common combos:

  • Minoxidil: Speeds up hair growth cycles. Comes in topical or oral form.
  • LLLT (low-level laser therapy): At-home laser caps that stimulate blood flow to follicles.
  • PRP (platelet-rich plasma): In-office injections of growth factors taken from your own blood.

These approaches are most effective when combined with a DHT-blocking medication. For a deeper look at complementary therapies, see our guide to non-surgical hair restoration options.

Cost & Convenience

Finasteride (1 mg daily): $10–20/month (generic)

Dutasteride (0.5 mg daily): $20–40/month (generic)

Topicals: Can run $60–90/month if compounded, especially for finasteride + minoxidil mixes.

Refill Cadence

  • Finasteride: Daily pill, clears fast (half-life ~6 hours)
  • Dutasteride: Can be taken less frequently in some cases (half-life ~5 weeks)

That long half-life makes dutasteride forgiving if you miss a dose—and some doctors prescribe it 2–3x/week instead of daily.

The Original Phase II Trial: Where It All Started

Before dutasteride became a mainstream off-label option, GlaxoSmithKline conducted a pivotal Phase II study that shaped everything we know about this medication’s potential for hair loss.

The trial enrolled 416 men with androgenetic alopecia (Norwood types IIIv, IV, or V) and compared multiple dutasteride doses against finasteride 5mg and placebo over 24 weeks, with a 12-week follow-up after stopping treatment.

What They Found: Hair Counts by Week

The results showed a clear dose-response relationship. Higher dutasteride doses produced more hair regrowth, and importantly, the effects lasted longer after stopping treatment.

TreatmentWeek 12 (hairs gained)Week 24 (hairs gained)Week 36 / 12 weeks after stopping (hairs maintained)
Dutasteride 0.05mg+5+25-17 (lost gains)
Dutasteride 0.1mg+54+72+17 (partial maintenance)
Dutasteride 0.5mg+72+96+84 (strong maintenance)
Dutasteride 2.5mg+100+110+120 (continued improvement)
Finasteride 5mg+52+73+13 (lost most gains
Placebo-23-30-37 (continued loss)

* Hair counts measured in a 1-inch diameter circle (0.79 square inches) at the vertex.

The Key Discovery

The most striking finding wasn’t just that dutasteride grew more hair. It was what happened after men stopped taking the medication.

At week 36, twelve weeks after discontinuing treatment, men on dutasteride 0.5mg and 2.5mg maintained nearly all their gains. Men on finasteride 5mg lost most of theirs, dropping from +73 hairs to just +13.

This durability effect is likely due to dutasteride’s exceptionally long half-life (5-6 weeks vs finasteride’s 6 hours). The medication stays in your system much longer, providing a “buffer” period after discontinuation.

Side Effects in the Original Trial

The trial also tracked adverse events across all groups:

Side EffectDutasteride 0.5mgDutasteride 2.5mgFinasteride 5mgPlacebo
Any adverse event16%+32%24%27%
Decreased libido0%13%4%3%
Headaches6%6%3%3%
Impotence0%+0%1%5%

At the 0.5mg dose (now the standard), sexual side effects were actually lower than placebo. The 2.5mg dose showed higher rates of decreased libido (13%), which is one reason the lower dose became standard practice.

Why This Still Matters

This Phase II data from over two decades ago established the scientific foundation for dutasteride’s off-label use in hair restoration. The 0.5mg dose emerged as the sweet spot: strong enough to produce meaningful results, low enough to minimize side effects.

Modern research has confirmed these early findings. The 2025 Gupta meta-analysis referenced earlier in this article builds on this foundation, showing dutasteride remains the most effective oral medication for androgenetic alopecia.

FAQs Men Ask in 2025

Does dutasteride ruin future transplants?

Not at all. In fact, it can preserve existing hair around transplanted areas, improving long-term results.

Can I switch from dutasteride back to finasteride?

Yes, though you may notice some regression if finasteride isn’t sufficient to maintain the gains achieved with dutasteride. Gradual tapering can help ease the transition and allow your provider to monitor any changes in shedding or density.

Will I lose hair if I stop taking it?

Yes. DHT levels return to normal, and miniaturization resumes. You’ll likely catch up to where you’d be without treatment.

Can I combine it with oral minoxidil?

Yes. This is a popular combo. Oral minoxidil stimulates regrowth while DHT blockers protect existing follicles.

Why isn’t dutasteride FDA-approved for hair loss if it works better?

GlaxoSmithKline conducted Phase II trials in the early 2000s but never completed the FDA approval process for hair loss. The exact reasons aren’t public, but likely factors include: the existing finasteride market, cost of Phase III trials, and the long half-life creating complex pregnancy warnings. Meanwhile, countries like Japan, South Korea, and Taiwan have approved it for hair loss.

Can I take dutasteride every other day instead of daily?

Yes, and some doctors prescribe it this way. Because dutasteride has a 5-6 week half-life (compared to finasteride’s 6 hours), it stays in your system much longer. Some men take it 2-3 times per week with good results. This approach may also reduce side effects. Discuss dosing frequency with your prescribing physician.

What happens if I switch from finasteride to dutasteride?

Most men who switch see additional improvement, particularly if finasteride wasn’t providing sufficient results. The transition is straightforward since both medications work through the same mechanism. You may notice increased shedding during the first few weeks as your body adjusts to the stronger DHT suppression, but this typically stabilizes.

Dutasteride vs Finasteride for Hair Loss – Conclusion

If you’re serious about keeping your hair, the best next step is a conversation with a hair restoration provider. At ForHair, we specialize in personalized treatment plans, including finasteride and dutasteride, as well as advanced therapies like stem cell, exosomes, and CRP therapy.

No one-size-fits-all. But the earlier you act, the more hair you keep

Let’s plan it right—Book your free consultation online to find out which option is right for your hair type, goals, and medical profile with our experts.

.

References:

  1. DHT (Dihydrotestosterone): What Is DHT’s Role in Baldness?” Www.medicalnewstoday.com.
  2. Drake L, Hordinsky M, Fiedler V, Swinehart J, Unger WP, Cotterill PC, Thiboutot DM, Lowe N, Jacobson C, Whiting D, Stieglitz S, Kraus SJ, Griffin EI, Weiss D, Carrington P, Gencheff C, Cole GW, Pariser DM, Epstein ES, Tanaka W, Dallob A, Vandormael K, Geissler L, Waldstreicher J. The effects of finasteride on scalp skin and serum androgen levels in men with androgenetic alopecia. J Am Acad Dermatol. 1999 Oct;41(4):550-4. PMID: 10495374.
  3. Almudimeegh A, AlMutairi H, AlTassan F, AlQuraishi Y, Nagshabandi KN. Comparison between dutasteride and finasteride in hair regrowth and reversal of miniaturization in male and female androgenetic alopecia: a systematic review. Dermatol Reports. 2024 Apr 12;16(4):9909. doi: 10.4081/dr.2024.9909. PMID: 39749123; PMCID: PMC11694415.
  4. Gubelin Harcha, Walter et al., A randomized, active- and placebo-controlled study of the efficacy and safety of different doses of dutasteride versus placebo and finasteride in the treatment of male subjects with androgenetic alopecia, Journal of the American Academy of Dermatology, Volume 70, Issue 3, 489 – 498.e3
  5. Gupta AK, Bamimore MA, Williams G, Talukder M. Comparative Efficacy of Minoxidil and 5-Alpha Reductase Inhibitors Monotherapy for Male Pattern Hair Loss: Network Meta-Analysis Study of Current Empirical Evidence. J Cosmet Dermatol. 2025 Jul;24(7):e70320. doi: 10.1111/jocd.70320. PMID: 40586152; PMCID: PMC12207719.
  6. Hirshburg JM, Kelsey PA, Therrien CA, Gavino AC, Reichenberg JS. Adverse effects and safety of 5-alpha reductase inhibitors (finasteride, dutasteride): a systematic review. J Clin Aesthet Dermatol. 2016;9(7):56-62.
  7. Roehrborn CG, Boyle P, Nickel JC, Hoefner K, Andriole G. Efficacy and safety of a dual inhibitor of 5-alpha-reductase types 1 and 2 (dutasteride) in men with benign prostatic hyperplasia. Urology. 2002;60(3):434-441. doi:10.1016/s0090-4295(02)01905-2
  8. Choi GS, Sim WY, Kang H, Huh CH, Lee YW, Shantakumar S, Ho YF, Oh EJ, Duh MS, Cheng WY, Bobbili P, Thompson-Leduc P, Ong G. Long-Term Effectiveness and Safety of Dutasteride versus Finasteride in Patients with Male Androgenic Alopecia in South Korea: A Multicentre Chart Review Study. Ann Dermatol. 2022 Oct;34(5):349-359.
  9. Min, Dan. “Dutasteride vs. Finasteride.” Innerbody, Innerbody Research, 17 Jan. 2025, www.innerbody.com/dutasteride-vs-finasteride. Accessed 30 July 2025.
  10. GlaxoSmithKline. Dutasteride Phase II Study ARIA2004 Report Synopsis. Data on file, 2001.
  11. Olsen EA, Hordinsky M, Whiting D, et al. The importance of dual 5alpha-reductase inhibition in the treatment of male pattern hair loss: results of a randomized placebo-controlled study of dutasteride versus finasteride. J Am Acad Dermatol. 2006;55(6):1014-1023.
Facebook
Twitter
LinkedIn
Reddit

Ready to Take the Next Step?

Are you eager to explore your hair restoration possibilities? Get ready to take action against that frustrating bald spot or thinning hair today, set up a complimentary FREE online consultation with one of our expert ForHair hair restoration specialists. By partnering with a ForHair Physician, we're dedicated to unraveling the root causes of your hair loss and determining the most suitable treatment path for your unique needs.

Contact TodayOnline Consultation
Dr. John P. Cole, MD - Medical Doctor and Hair Transplant Physician

John Cole, MD - ForHair Atlanta & New York

Dr. John P. Cole, MD, and the team at ForHair offer world-class hair restoration backed by over 35 years of specialized expertise. Since 1990, Dr. Cole has dedicated his practice exclusively to advancing hair transplant surgery, transforming the field from cosmetically unacceptable results into natural, aesthetically refined outcomes.

Dr. John P. Cole identified as a pioneer of modern Follicular Unit Extraction (FUE) in 2003, developing the Cole Isolation Technique with 97%+ graft yield and a minimal depth approach that preserves stem cells, enabling 30-40% donor follicle regeneration.

Keep reading...